125 related articles for article (PubMed ID: 37879153)
1. Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway.
Zhang YR; Liu SM; Chen Y; Zhang LS; Ji DR; Zhao J; Yu YR; Jia MZ; Tang CS; Huang W; Zhou YB; Chai SB; Qi YF
Atherosclerosis; 2023 Nov; 385():117342. PubMed ID: 37879153
[TBL] [Abstract][Full Text] [Related]
2. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
3. Intermedin
Ren JL; Hou YL; Ni XQ; Zhu Q; Chen Y; Zhang LS; Liu X; Xue CD; Wu N; Yu YR; Tang CS; Ning ZP; Chai SB; Qi YF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):251-264. PubMed ID: 31698947
[TBL] [Abstract][Full Text] [Related]
4. Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.
Cai Y; Xu MJ; Teng X; Zhou YB; Chen L; Zhu Y; Wang X; Tang CS; Qi YF
Cardiovasc Res; 2010 Mar; 85(4):864-73. PubMed ID: 19910445
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
6. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
[TBL] [Abstract][Full Text] [Related]
7. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.
Brodeur MR; Bouvet C; Bouchard S; Moreau S; Leblond J; Deblois D; Moreau P
PLoS One; 2014; 9(1):e85922. PubMed ID: 24465790
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway.
Chen K; Jin HJ; Wu ZH; Zhang BF; Wu J; Huang ZY; Huang YP; Lu XW; Zheng XT
Mol Med; 2024 May; 30(1):58. PubMed ID: 38720283
[TBL] [Abstract][Full Text] [Related]
9. Intermedin
Chen Y; Zhang LS; Ren JL; Zhang YR; Wu N; Jia MZ; Yu YR; Ning ZP; Tang CS; Qi YF
Aging (Albany NY); 2020 Mar; 12(7):5651-5674. PubMed ID: 32229709
[TBL] [Abstract][Full Text] [Related]
10. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
[TBL] [Abstract][Full Text] [Related]
11. Intermedin Alleviates Vascular Calcification in CKD through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress.
Liu SM; Zhang YR; Chen Y; Ji DR; Zhao J; Fu S; Jia MZ; Yu YR; Tang CS; Huang W; Zhou YB; Qi YF
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297336
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway.
Cai Y; Teng X; Pan CS; Duan XH; Tang CS; Qi YF
Acta Pharmacol Sin; 2010 Oct; 31(10):1359-66. PubMed ID: 20802507
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
14. Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway.
Chang JR; Duan XH; Zhang BH; Teng X; Zhou YB; Liu Y; Yu YR; Zhu Y; Tang CS; Qi YF
Exp Biol Med (Maywood); 2013 Oct; 238(10):1136-46. PubMed ID: 24006303
[TBL] [Abstract][Full Text] [Related]
15. Advanced Glycation End Products Impair Ca2+ Mobilization and Sensitization in Colonic Smooth Muscle Cells via the CAMP/PKA Pathway.
Yu T; Wang Y; Qian D; Sun X; Tang Y; Shen X; Lin L
Cell Physiol Biochem; 2017; 43(4):1571-1587. PubMed ID: 29035879
[TBL] [Abstract][Full Text] [Related]
16. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
[TBL] [Abstract][Full Text] [Related]
17. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats.
Li P; Sun HJ; Han Y; Wang JJ; Zhang F; Tang CS; Zhou YB
Peptides; 2013 Sep; 47():1-6. PubMed ID: 23816795
[TBL] [Abstract][Full Text] [Related]
18. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease.
Wang PW; Pang Q; Zhou T; Song XY; Pan YJ; Jia LP; Zhang AH
Atherosclerosis; 2022 Apr; 346():36-45. PubMed ID: 35255258
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolism.
Zhu Y; Ma WQ; Han XQ; Wang Y; Wang X; Liu NF
Sci Rep; 2018 Sep; 8(1):13730. PubMed ID: 30213959
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
